Antonio Colaprico

University of Miami — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index25.1kcitations104works14.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(35), Cancer Genomics and Diagnostics(30), Bioinformatics and Genomic Networks(24), Ferroptosis and cancer prognosis(23), RNA modifications and cancer(17)

Publications103 total

Abstract 5026: Discovery of oncogenic mediator genes in rectal cancer chemotherapy response using gene expression data from matched tumor and patient-derived organoids
Cancer Research·2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Cell Genomics·2025· 3 citedOpen Access
Precision proteogenomics reveals pan-cancer impact of germline variants
Cell·2025· 4 citedOpen Access
Abstract LB004: Deciphering oncogenic dedifferentiation: A proteomic approach to quantifying stemness scores and unveiling druggable targets
Cancer Research·2024
Pan-cancer proteogenomics characterization of tumor immunity
Cell·2024· 76 citedOpen Access
Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived Organoid
2024· 1 citedOpen Access
IoT sensor nodes for air pollution monitoring: A review
ACTA IMEKO·2023· 9 citedOpen Access
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Cancer Cell·2023· 90 citedOpen Access
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Cell Reports Medicine·2023· 30 citedOpen Access
A workflow to study mechanistic indicators for driver gene prediction with Moonlight
Briefings in Bioinformatics·2023· 8 citedOpen Access
Proteogenomic data and resources for pan-cancer analysis
Cancer Cell·2023· 197 citedOpen Access
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Cell·2023· 156 citedOpen Access
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cell·2023· 92 citedOpen Access
Abstract LB061: Proteomic-based stemness score measure oncogenic dedifferentiation and enable the identification of druggable targets
Cancer Research·2023
Table S8 from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
Table S2 from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
Table S11 from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
Table S2 from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
Data from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
Table S1 from Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Gad Getz(21), Li Ding(20), David I. Heiman(17), Ana I. Robles(17), Gianluca Bontempi(16), Henry Rodriguez(16), David Fenyö(16), Alexey I. Nesvizhskii(16), Chet Birger(16), Song Cao(15), Mehdi Mesri(15), Bing Zhang(15), D.R. Mani(15), Tiago C. Silva(14), Yize Li(14), Boris Reva(14), Felipe da Veiga Leprevost(14), Tara Hiltke(14), Houtan Noushmehr(13), Alexander J. Lazar(13)